scholarly journals CARCINOMA OF THE THORACIC ESOPHAGUS

1937 ◽  
Vol 7 (1) ◽  
pp. 38-42
Author(s):  
Harold Brunn ◽  
H. Brodie Stephens
Keyword(s):  
Thoracic Esophagus

A Case of Esophageal Xanthoma with Epithelial Reactive Inflammation with a Characteristic Finding of Narrow-Band Imaging Magnifying Endoscopy

2019 ◽  
Vol 38 (1) ◽  
pp. 85-88
Author(s):  
Hideki Mori ◽  
Motohiko Kato ◽  
Toshio Uraoka
Keyword(s):  
Biopsy Specimen ◽  
Narrow Band ◽  
Narrow Band Imaging ◽  
Basal Layer ◽  
Excisional Biopsy ◽  
Magnifying Endoscopy ◽  
Thoracic Esophagus ◽  
Characteristic Finding ◽  
Capillary Loop ◽  
White Substance

A 75-year-old woman had a 5 mm slightly elevated yellowish lesion in her thoracic esophagus. Narrow-band imaging magnifying endoscopy (NBI-ME) revealed aggregations of a tiny white substance beneath each intrapapillary capillary loop with weaving, dilatation, and a different shape. In this case, an irregular caliber was absent. The biopsy specimen taken from the lesion showed cells with large nuclei and increased chromatin clumping in the basal layer. These cells were positive for p53. Endoscopic submucosal dissection was performed for the purpose of excisional biopsy. Finally, it was diagnosed as an esophageal xanthoma with a benign epithelial reactive inflammation. This is the first report of esophageal xanthoma showing the characteristic NBI-ME finding of esophageal xanthoma. Further studies are required to determine whether the characteristic finding of NBI-ME is generally found in esophageal xanthomas.

scholarly journals RESECTION OF THE THORACIC ESOPHAGUS

1938 ◽  
Vol 7 (6) ◽  
pp. 605-620 ◽  
Author(s):  
W.E. Adams ◽  
L. Escudero ◽  
H.G. Aronsohn ◽  
M.M. Shaw
Keyword(s):  
Thoracic Esophagus

Analysis of results of surgery performed over a 20-year period on 500 patients with cancer of the thoracic esophagus

Surgery Today ◽  
1996 ◽  
Vol 26 (2) ◽  
pp. 77-82 ◽  
Author(s):  
Shichisaburo Abo ◽  
Michihiko Kitamura ◽  
Masaji Hashimoto ◽  
Keiichi Izumi ◽  
Yoshihiro Minamiya ◽  
...  
Keyword(s):  
Thoracic Esophagus ◽  
Patients With Cancer ◽  
Analysis Of Results ◽  
Results Of Surgery

Cardiac tamponade as an unusual initial presentation of squamous cell carcinoma of the esophagus

2021 ◽  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Esophageal Cancer ◽  
Pericardial Effusion ◽  
Cell Carcinoma ◽  
Cardiac Tamponade ◽  
Squamous Cell ◽  
Unknown Etiology ◽  
Thoracic Esophagus ◽  
Moderate Amount ◽  
Carcinoma Of The Esophagus

Pericardial effusions leading to cardiac tamponade have previously been described with esophageal cancer. However, up to eighty percent of these cases have been reported in association with chemotherapy and radiation. Patients with esophageal cancer seldom initially present with pericardial effusion resulting from esophageal pericardial fistula (EPF). Herein, we present the case of a 62-year-old man who presented with pericardial effusion with an unknown etiology at presentation. Subsequently, the patient developed cardiac tamponade and was referred to the tertiary hospital for further evaluation. Computed tomography of the chest revealed a circumferential irregular enhancing lesion at the mid-thoracic esophagus suspecting esophageal cancer with EPF and a moderate amount of pericardial effusion. The patient underwent esophagoscopy and squamous cell carcinoma was found from the esophageal biopsy. An esophageal stent was successfully placed to conceal the perforation. Eventually, the patient died 13 days after admission complicated by refractory septic shock. This case highlights an atypical presentation of esophageal cancer and an unusual cause of cardiac tamponade.

scholarly journals Assesment of placement of the esophageal self-expandable metallic stent in esophageal cancer in patients with or without citorreduction therapy

2007 ◽  
Vol 20 (3) ◽  
pp. 154-160
Author(s):  
Gilson Kamiyama ◽  
Paulo Sakai ◽  
Eduardo Guimarães H. de Moura ◽  
Shinichi Ishioka ◽  
Ivan Cecconello ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Survival Time ◽  
Stent Placement ◽  
Gastrointestinal Endoscopy ◽  
Thoracic Esophagus ◽  
Metallic Stent ◽  
Advanced Esophageal Cancer ◽  
Expandable Metallic Stent ◽  
Stent Treatment ◽  
Time Average

BACKGROUND: Placement of self-expanding metallic esophageal stent in patients with advanced esophageal cancer offers excellent palliation of dysphagia and tracheo-esophageal fistulas. However, the safety of stent in patients undergoing radio and/or chemotherapy is controversial, in terms of the greater risk of complications in cases where these two treatments are used in conjunction. AIM: To assess the use of stent in patients with advanced cancer of the mid-thoracic esophagus, by comparing patients undergoing cytoreductive therapy with patients who have not undergone this treatment, in relation to improvement in the dysphagia, rate of complications, period of effectiveness and survival time. METHODS: Fifty seven patients were evaluated retrospectively (16 women and 41 men, with an average age 62 years) with advanced squamous cell carcinoma of the mid-thoracic esophagus who underwent placement of the Ultraflex™ self-expandable metallic coated stent, at the Gastrointestinal Endoscopy Unit of São Paulo University Medical School between October 1988 and October 2004. Out of the 57 patients, 24 patients received adjuvant cytoreductive therapy, and 33 patients were only treated with the stent placement. RESULTS: After stent placement, there was improvement in dysphagia in both groups; there were no differences in the rate of complications, such as migration, pain, fistula, obstruction and compression of the airways; the period of effectiveness was significantly higher in the group submitted to cytoreductive therapy (average 123 days compared to 63 days), as was the survival time (average of 210 days, compared with 120 days). CONCLUSIONS: Improvement in dysphagia was statistically significant in both groups, irrespective of whether the patient had undergone adjuvant cytoreductive therapy; there were no differences in the rate of complications between the two groups and both the period of effectiveness of the stent treatment and the survival time were higher in the group with adjuvant cytoreductive therapy.

Sign in / Sign up

Export Citation Format

Share Document